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Abstract
Endometriosis is a common, chronic disease. Patients typically 
present with pelvic pain, infertility, and/or an adnexal mass. Results 
from the limited number of studies that have been published indicate 
that the true prevalence of endometriosis, along with the associated 
infertility, has been increasing. Debates about infertility management 
arise from the contradiction between the contraceptive nature of 
medical treatments for endometriosis and the unpredictable ovarian 
reserve after surgery. There is moderate quality evidence that surgery 
increases clinical pregnancy rate and live birth in minimal to mild 
endometriosis. However, insufficient evidences which supports the 
effect of surgery in moderate to severe endometriosis in term of 
subfertility. On this basis, artificial reproductive technologies have 
been become the most efficient way of overcoming endometriosis-
associated infertility, particularly in stage III/IV endometriosis. The 
objective of this paper is to review recent trends in endometriosis, from 
the pathophysiology of the disease to the management of infertility. 
endometriosis and infertility and to assess the current approaches and 
management modalities used for infertile women with endometriosis. 
Pathophysiology
As previously mentioned, how endometriosis contributes to 
infertility remains controversial. However, there are a few hypotheses 
that describe the pathophysiology of endometriosis-associated 
infertility when the endometriotic lesion is located in the pelvic 
cavity, ovary, or uterus [8].
Distorted Pelvic Anatomy 
Pelvic adhesions that develop as a consequence of endometriosis 
can interfere with ovulation, transport of the oocyte or ovum, and 
pick-up by the fimbriae. The oviducts may be patent bilaterally, but 
existing adhesions around the adnexa can interrupt the dynamic 
movements of the fimbriae that are necessary for oocyte uptake [9].  
Altered Peritoneal Milieu
The chronic inflammatory status of the pelvic cavity in 
endometriosis patients has been recognized for decades. This 
inflammation is accompanied by increased infiltration of 
macrophages in the pelvic fluid. The pathophysiology has not 
been well-described, but increased recruitment of immune cells 
and dysregulated apoptosis of endometrial cells present in the 
lesion are thought to be contributing factors. Additional support 
for this hypothesis arises from the observation that in addition to 
the macrophages, inflammatory cytokines, and prostaglandins, 
chemokines stimulate and aggregate monocytes and granulocytes. 
RANTES [10], monocyte inflammatory protein-1[11,12], eotaxin 
[13], interleukin-8 [14], and ENA-78 [15] have been identified in 
peritoneal fluid of endometriosis patients. Increased numbers of 
macrophages with phagocytic dysfunction, abnormal activation, and 
altered Th1/Th2 immunity, [16] have also been reported. Abnormal 
survivability of endometrial cells regurgitated into the peritoneal 
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Introduction 
Endometriosis is a disease characterized by ectopic endometrial 
glands and stromal tissue external to the uterine cavity. The 
prevalence of the disease has been reported to be 5–10% in women 
of reproductive age, 20–30% in women diagnosed with infertility, 
and 40–60% in women with chronic pelvic pain [1]. Fecundity, the 
probability of giving live birth in a menstrual cycle, has been shown 
to be 0.02–0.1 per month in women with endometriosis, but is 
0.15–0.2 per month in normal women [2]. The live birth rate is also 
significantly decreased in women with endometriosis [2]. 
The pathophysiology of endometriosis has not been clarified. 
However, pain in endometriosis patients has been correlated with 
disease severity, degree of endometrial tissue infiltration, and the 
location of the lesion [3-5]. Although endometriosis seems to be highly 
related to infertility, how endometriosis contributes to infertility 
remains controversial [6]. The generally accepted process includes 
induction of local inflammation by estrogen-dependent ectopic 
endometriotic lesions that serially induce endometrial fragment 
adhesion, proliferation, and neovascularization, with subsequent 
development of fibrosis, adhesions, and distortion of the pelvic 
anatomy [3,6,7]. Infertility in women with endometriosis is thought 
to have multifactorial causes that can interfere with reproduction. 
 The management of infertility in endometriosis patients should 
be considered in the context of understanding the pathophysiology 
between endometriosis and fertility. Medical treatment of 
endometriosis includes the use of gonadotropin-releasing hormone 
agonists, oral contraceptives, and progestins, which mainly suppress 
the secretion of estrogen from the ovary. These approaches cannot 
be used for women who are planning to conceive. When surgery and 
medical treatment fail or natural conception becomes impossible, 
assisted reproductive techniques (ARTs) are other options. The 
primary objective of this review is to examine the pathophysiology of 
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cavity is associated with overexpression of anti-apoptotic factors and 
suppression of pro-apoptotic factors [17,18]. Because the peritoneal 
fluid surrounds the pelvic organs, and the ampulla is exposed to the 
fluid, change in the milieu can affect fertilization that occurs in the 
ampulla. Ultimately, an altered peritoneal milieu might negatively 
affect oocyte, sperm, embryo, or tubal function. 
Impaired Implantation 
Recently, decreased expression of integrin-αvβ3 has been found in 
the endometrium of endometriosis patients [19]. This abnormality 
may cause implantation failure. Increased immunoglobulin A and 
G, and lymphocytes in the endometrium as a result of peritoneal 
inflammation have been suggested to affect implantation and 
endometrial receptivity [7]. 
 Alteration of the endometrial milieu in women with endometriosis 
results from changes that include abnormal production of estradiol by 
local inflammation. Progesterone resistance is also well known. It was 
also suggested that cyclooxygenase-2 (COX-2) expression increased 
in the eutopic endometrium as well as ovarian endometriotic tissue 
in patients with endometriosis [20]. The alteration contains abnormal 
prostaglandin production in the eutopic endometrium, and abnormal 
activation of the inflammation loop by cytokines. These processes can 
result in local production of estradiol, which increases peristalsis of 
the myometrium. There is little evidence that supports the hypothesis 
that alteration of the endometrium induces implantation and 
ultimately affects the pregnancy rate, but results indicate that there 
are obvious differences when compared with eutopic endometrium 
from normal women. 
Endocrine and Ovulatory Abnormalities 
It is generally accepted that ovulatory problems associated with 
endometriosis are related to decrease of ovarian function caused by 
repeated surgery from the endometrioma, or by the endometrioma 
itself which result in space-occupying effects, local reactions, and 
reduction of available functional ovarian tissue. 
Ovulation of immature oocytes that induce an impaired luteal 
phase and abnormal folliculogenesis and abnormal follicular 
maturation in endometriosis patients have been suggested to cause 
endocrinologic ovulatory disorders. In early studies, ovulatory 
dysfunction or alteration were suggested to be responsible for the 
lower implantation rate in women with endometriosis [21,22]. 
Recently, altered expression of estrogen and progesterone receptors 
in granulosa cells have been found in advanced stage endometriosis 
[23]. This altered expression might contribute to an explanation of the 
cause of ovarian dysfunction in endometriosis. The hypothesis that 
endometrioma affects oocyte quality has been controversial. Some 
investigators have reported that the fertilization rate is reduced in 
women with endometriosis. However, ART data that have indicated 
that pregnancy rates are preserved suggest that the effect on oocyte 
quality may be minimal in women with endometriosis. 
Management of Infertility 
Among the management options for endometriosis, surgery is the 
only option that can improve the chances that pregnancy will occur. 
However, surgery cannot be used for all patients. If possible, surgery 
should be offered as early as the diagnostic work up stage, because 
surgery increases the chances for successful natural conception. 
The evidence from a randomized trial performed by Marcoux et 
al. provides support for this recommendation [24]. The odds ratio 
(OR) for spontaneous pregnancy was 1.66 [95% confidence interval 
(CI) 1.09–2.51] after surgical removal of superficial endometriosis. 
However, although cumulative pregnancy rate seems to increase 
after conservative surgery in mild to moderate endometriosis [25], in 
patients who are planning to undergo the ART, whether the surgical 
management shall be proceeded or not remains uncertain [26]. It 
has been shown that surgery could reduce ovarian reserve or ovarian 
response to gonadotropin without improving pregnancy outcomes in 
women undergoing IVF. In recent review, the opinion suggested that 
ovarian surgery for removal of endometrioma seemed to lower ovarian 
reserve. Furthermore, they pointed that removing endometrioma 
did not affect the quality of oocyte in IVF cycle as an evidence of 
no additional advantage of surgery in ART cycle [27]. On the other 
hand, some investigators did not support the same opinion [28-31]. 
It is clear that considerable surgical expertise is requied to decrease 
ovarian damage and avoid incomplete surgery [32]. It was suggested 
that the presence of ovarian endometrioma as per se is associated with 
a reduced responsiveness to gonadotropins [33]. There is growing 
evidence that endometrioma per se decreases follicular density in the 
ovarian cortex [34]. It was suggested that laparoscopic management 
of endometriomas may be beneficial to protect the ovarian 
reserve in women with endometriomas. Considering the relevant 
recommendations and evidences, at least 12 months is necessary to 
achieve a natural pregnancy after surgery. Patient characteristics that 
should be considered when deciding whether to stress the advantages 
of surgery include patient age and ovarian reserve, and the capacity 
to conceive naturally. If the patient has decreased ovarian reserve, 
is >38 years of age, or has experienced a long duration of infertility, 
use of direct ARTs might be more appropriate. If infertile couple 
has been combined with male factor or tubal factor additionally 
to endometriosis, ART would be a better choice. If the patient has 
simultaneously existing pelvic pain, hydrosalpinx, or one or more 
endometriomas >3-4cm diameter, surgery could be considered 
as the first option. The strategies briefly summarized above are in 
accordance with the guidelines of the European Society of Human 
Reproduction and Embryology(ESHRE) [35] and American Society 
for Reproductive Medicine(ASRM) [36]. A detailed discussion with 
supporting evidence follows in this manuscript.
I. Medical management 
 Medical treatments for endometriosis (e.g., oral contraceptives, 
progestin, gonadotropin releasing hormone analogs, and aromatase 
inhibitors) inhibit ovarian function by suppressing ovulation. Medical 
treatments are effective for pain relief and to prevent postoperative 
recurrence, but are ineffective for recovery of fecundity [37]. The 
results of a Cochrane review indicated that patients with ovulation 
suppression did not have an increased odds of successful pregnancy 
(OR0.74, 95% CI 0.48–1.15), compared with the placebo or untreated 
groups [38]. Overall, the results of randomized studies of minimal 
to mild endometriosis have indicated that there is no improvement 
in pregnancy rate with any medical treatment or with expectant 
management [39-41]. The results of a meta-analysis comparing 
medical treatment to no treatment or placebo indicated that the OR 
for pregnancy is 0.85 (95% CI 0.95–1.22) [42]. 
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II. Surgical treatment 
Laparoscopy is the most effective modality for diagnosis and 
staging of endometriosis. Surgery can help to recover the distorted 
pelvic anatomy and increase the chances for natural conception. 
However, surgery cannot improve the biochemical environment 
associated with endometriosis, such as the increased inflammatory 
factors and the altered endometrial milieu. 
The indications for laparoscopic surgery in endometriosis 
patients are diagnosis of infertility in women when the cause is 
unknown, severe dyspareunia, dysmenorrhea, or chronic pelvic 
pain, suspicious deep infiltrating endometriosis, a tender nodule on 
uterosacral ligament revealed by a pelvic examination, and suspicion 
of, or diagnosis of ovarian endometrioma.
Surgical Treatment for Minimal to Mild Endometriosis 
(Stage I/II) 
The results of observational studies have suggested that 
laparoscopic surgery does not affect postoperative conception 
in patients with minimal to mild endometriosis. However, a 
randomized controlled trial (RCT)that evaluated the effectiveness 
of laparoscopic surgery for stage I/II endometriosis in infertile 
patients revealed that the use of laparoscopic surgery increases the 
live birth rate[24]. Based on a systematic review and meta-analysis, 
the ESHRE guideline has proposed that compared with diagnostic 
laparoscopy, ablation of endometriotic lesions with adhesiolysis 
in minimal to mild endometriosis improves fertility[43].A more 
recent meta-analysis revealed that the live birth rate increases (OR 
1.94, 95% CI 1.2–3.16), and the clinical pregnancy rate increases (OR 
1.89, 95% CI 1.25–2.86), in laparoscopic ablation or excision patients 
comparedwith diagnostic laparoscopy patients in women with stage 
I/II endometriosis[25]. 
Surgical Treatment for Moderate to Severe 
Endometriosis (Stage III/IV) 
There have been no results available from RCTs or meta-
analyses that indicate whether surgical management of stage III/IV 
endometriosis improves pregnancy rates. Laparoscopic cystectomy 
for ovarian endometrioma >3-4cm results in improvements in 
pregnancy rates compared with cyst drainage and coagulation [44]. 
Although in a review by Vercellini et al. demonstrated that the overall 
weighted mean of pregnancy rate after laparoscopic treatment of 
ovarian endometrioma in stage III/IV was about 50%, they also stated 
that it is most likely to be overestimated due to multiple confounding 
factors [37]. The evidences from observational studies suggest that 
women who have stage III/IV endometriosis without any other 
identifiable infertility factors may benefit from surgical treatment 
to increase fertility [45,46]. However, the potential adverse effects 
should be considered. For example, the loss of viable ovarian cortex 
may lead to a decrease in ovarian function. 
Surgical Treatment for Other Conditions in 
Endometriosis: Rectovaginal Lesions, Recurrent 
endometriosis 
Rectovaginal endometriosis usually results in severe pain that is a 
consequence of deep, infiltrating endometriosis. The primary objective 
of surgical treatment of rectovaginal endometriosis is pain relief. The 
resection of the rectovaginal lesion has been reported to significantly 
relieve the pain, but is ineffective for fertility enhancement. 
Few studies have been performed that examine options for 
second-line surgery for patients with recurrent endometriosis. 
Repeated surgery has only rarely increased fecundity [47,48], and 
ASRM has recommended ART for patients who have a history of 
at least one surgical treatment [36]. The results of another meta-
analysis suggested that expectant management followed by ART may 
result in a better prognosis for pregnancy compared with repeated 
surgery in women with recurrent endometriosis [31]. However, if 
the patients suffer from severe pain or from endometrioma >4cm, 
the Royal College of Obstetricians and Gynecologists(RCOG) has 
recommended that repeated surgery could be considered [49]. 
Guidelines 
ESHRE [35], ASRM [36], and RCOG [49] commissions have 
suggested guidelines for infertility management in women with 
endometriosis that have mostly coincided (Table 1). Surgical 
treatment has demonstrated benefit in stage I/II endometriosis 
in ESHRE and RCOG guidelines, but insufficient benefit to be 
recommended solely to increase the likelihood of pregnancy in 
ASRM guideline. Surgical treatment is a possible treatment modality 
for stage III/IV endometriosis in all three guidelines. Postoperative 
adjuvant management is not currently recommended; because 
there is little evidence that the postoperative ovarian suppression 
effects may improve future fertility. Although controversial, all three 
committees recommended that surgical treatment can be performed 
before ART for patients with endometrioma >3-4cm especially to 
improve endometriosis-associated pain or accessibility of follicles 
or to detect occult malignancy. The ASRM committee opinion was 
that ART rather than repeated surgical procedures should be used for 
women with recurrent endometriosis.
III. Role of postoperative hormonal treatment 
The results of a meta-analysis of six case-control studies 
indicated that there is a significant improvement in pain after 3 to 6 
months of postoperative GnRH agonist, danazol, or combined oral 
contraceptives use, compared with untreated and placebo groups. 
However, a systematic review that compared comparative studies 
revealed that there were no significant differences in pregnancy rate 
among groups (i.e., surgery, surgery with a postoperative placebo, 
and surgery with postoperative hormonal treatment) [50].
Iv. Assisted Reproductive Technology in Women with 
Endometriosis 
Intrauterine insemination
Intrauterine insemination (IUI) has been used in a number of cases 
of subfertile couples, and the pregnancy rate has increased somewhat. 
Some studies have reported a modest benefit of IUI in women with 
minimal and mild endometriosis [51-55] (Table 2). In particular, IUI 
with controlled ovarian stimulation (COS) resulted in increases in 
pregnancy rate compared with expectant management in a few large 
RCTs and in a large population study [56-58]. The results of an RCT 
performed by Tummon et al. indicated that IUI with stimulated cycles 
significantly increases pregnancy rate (OR 5.6, 95% CI 1.8–17.4) 
[56]. The results of a systematic review of six RCTs indicated that 
the pregnancy rate was higher per IUI cycle with clomiphene citrate, 
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Clinical condition ESHRE 2014 ASRM 2012 RCOG 2006
Minimal-mild  
(stage I-II)
Demonstrated benefit :  
surgery recommended
Small benefit: 
insufficient to recommend surgery solely to 
increase the likelihood of pregnancy
Demonstrated benefit: surgery 
recommended
Moderate-severe  
(stage III-IV)
Possible benefit: 
surgery can be considered
Possible benefit: 
surgery may be beneficial
Possible benefit:  
recommendation uncertain
Postoperative adjuvant treatment No benefit :  not recommended
No benefit:  
not recommended
No benefit:  
not recommended
Surgery before IVF
Uncertain benefit in stage I –II: may be 
considered 
No benefit 
if endometrioma>3cm: 
only consideredto improve pain or the 
accessibility of follicles 
Insufficient benefit: 
no recommendation 
surgery should be considered  
if endometrioma> 4cm
Recommended  
if endometrioma 
> 4cm
Recurrent endometriosis Surgery should be considered carefully if the women has had previous ovarian surgery
Second-line surgery not recommended; IVF-
ET is an effective alternative No recommendation
Table 1: International guidelines for surgical treatment of endometriosis-associated infertility in asymptomatic women.
IVF, in vitro fertilization; ET, embryo transfer
Group Unexplained Endometriosis-associated infertility
Treatment Guzick  et al. (1999)
Deaton at al. 
(1990)
Chaffkin et al. 
(1991)
Fedele et al. 
(1991)
Kemmann et al. 
(1993)
No treatment or intracervical insemination 0.02 0.033 - 0.045 0.028
IUI 0.05* - - - -
Clomiphene - - - - 0.066
Clomiphene/IUI - 0.095* - - -
Gonadotropins 0.04* - 0.066 - 0.073*
Gonadotropins/IUI 0.09* - 0.129* 0.15* -
IVF - - - - 0.022*
Table 2: Cycle fecundity in women with stage I/II endometriosis by treatment.
IUI, intrauterine insemination; IVF, in vitro fertilization. * P<0.05 for treatment vs. no treatment.
compared with timed intercourse during the natural cycle (OR 4.6, 
95% CI 1.9–11.3) [57]. Clinical pregnancy rate using IUI with COS 
after surgical management for stage I/II endometriosisis comparable 
to the rate associated with unexplained infertility. The controlled 
cohort study revealed that clinical pregnancy rate per cycle is 21%, 
18.9%, and 20.5% for minimal endometriosis, mild endometriosis, 
and unexplained infertility, respectively. Moreover, cumulative live 
birth rates in first four cycles of IUI are also comparable between 
groups (70.2%, 68.2%, and 66.5%, respectively) [59]. Thus, IUI with 
COS may be considered as an option for patients with minimal/mild 
endometriosis. However, endometriosis itself has a considerable 
adverse impact on success of IUI compared with other causes such 
as unexplained infertility. Nuojua-Huttunen et al. reported that 
pregnancy rates per cycle were 15.3% for unexplained infertility 
versus 6.5% for patients with endometriosis [60]. We performed 
retrospective analysis to determine predictive factors for pregnancy 
in patients undergoing the first four IUI cycles. the pregnancyrate 
was 4.2% (2/48) in cases of endometriosis-related infertility, which 
was lower than in male factor infertility (13.3%, 4/30) as well as 
unexplained infertility (17.2%, 48/279) with borderline significance 
(P=0.064), and endometriosis-related infertility was an unfavorable 
predictive factor in logistic regression. Low pregnancy rate in patients 
with endometriosis could be due to advanced stage with 18 cycles with 
moderate endometriosis and 27 cycles with severe endometriosis [61]. 
It is unclear whether IUI is a better option after surgical diagnosis 
of endometriosis compared with clinically diagnosed or untreated 
endometriosis. 
In Vitro Fertilization and Embryo Transfer 
IVF may represent a viable option that overcomes the influence 
of distorted pelvic anatomy in infertile women with endometriosis. 
However, because few studies have been performed that evaluate 
whether IVF is superior to expectant management for patients with 
endometriosis, it is not a treatment of choice for infertile women with 
endometriosis. Yet, similar to patients without endometriosis, IVF is 
used for infertile couples with male factor and tubal factor issues, or 
who have repetitively failed to conceive. Although most of the results 
from recent studies have suggested that endometriosis does not affect 
the IVF outcome after adjusting for age, some discrepancies have 
been reported. Some of the studies have reported lower fertilization 
[62] or implantation rates [22,63], altered oocyte quality [22,23], and 
lower pregnancy rates in endometriosis patients, compared with the 
controls.
Findings of early retrospective studies indicated that delivery 
rate per embryo transfer was comparable for endometriosis patients 
compared with patients with tubal factor issues [64,65]. A serial 
prospective study also obtained similar results, the presence and 
severity of endometriosis seems not to alter the IVF outcome [66]. In 
the early 2000s, a meta-analysis that included 27 trials compared the 
outcome of IVF for patients with endometriosis with that of women 
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undergoing IVF for other indications [67]. The chance of achieving 
pregnancy was significantly lower in endometriosis patients (OR 0.56, 
95% CI 0.44–0.70), compared with the tubal controls. Fertilization 
and implantation rates were also significantly lower. Fewer oocytes 
were retrieved from the endometriosis patients after adjusting for age, 
stimulation protocol, and publication date. In a large, retrospective, 
cohort study performed in Norway, the investigators compared 
couples with minimal/mild endometriosis, tubal factor issues, and 
unexplained infertility [68]. The live birth rate was similar between 
the endometriosis and tubal factor groups (66.0% and 66.7%, 
respectively). The birth rates for these groups were lower than the 
rate for the unexplained factor group, which was 78.8% (P < 0.05). 
The implantation rate was comparable among the three study groups. 
The discrepancies among studies comparing the effect of 
endometriosis on IVF outcome may be caused by variations in the 
severity of the endometriosis among the participants. The results of 
a retrospective study performed in Israel indicated that there were 
significantly lower fertilization, pregnancy, and birth rates per IVF 
cycle in advanced stage (stage III/IV) endometriosis compared with 
tubal controls [69]. However, one limitation of the study is that it did 
not include minimal/mild endometriosis in the comparison. Some 
studies have reported unaffected pregnancy outcomes according 
to the stage [64,65], and others have found significantly decreased 
fertilization rates in stage III/IV endometriosis [70]. Recently, results 
of an observational study indicated that implantation and pregnancy 
rates in women with stage III/IV endometriosis were significantly 
lower compared with milder stages of endometriosis or tubal factors, 
independent of age. Also, deep infiltrating endometriosis has not 
been included in the American Fertility Society staging definition, 
but it has been suggested to deleteriously affect pregnancy outcome, 
compared with superficial lesions [71,72]. 
The effect of existing endometrioma on ART outcome has been 
debated. There have been no randomized studies comparing IVF/
ICSI outcomes between expectant management and surgical treated 
groups. Moreover, the effect of endometriomaon IVF outcome is 
difficult to evaluate because endometrioma rarely occurs without 
peritoneal lesions or adhesions. Surgical removal of endometrioma 
can have possible benefits, particularly for larger endometriomas, and 
can prevent incidental or iatrogenic rupture of the endometrioma 
during oocyte retrieval, early detection of ovarian malignancy, and 
easier oocyte retrieval. The disadvantages of surgical removal include 
potential surgical complications, decreased ovarian reserve after 
surgery, economic costs, and lack of definitive evidence for a positive 
effect on ART outcome. The results of a case control study indicated 
that there is no effect on ART outcome when endometrioma is 
removed laparoscopically before IVF [73]. The authors of a recent 
Cochrane review concluded that neither aspiration nor cystectomy 
before ART further improves pregnancy rate [74]. 
The systematic review that summarized three RCTs concluded 
that administrating GnRH agonists for 3 to 6 months prior to ART in 
women with endometriosis increases the odds of clinical pregnancy 
(OR 4.28, 95% CI 2.00–9.15). Short-term use of oral contraceptives 
prior to ART can be as effective as the use of a GnRH agonist, but 
further study is necessary [75]. It has been shown that use of a GnRH 
agonist might improve ART outcome, but it is unclear whether 
pretreatment is beneficial for every stage of the endometriosis, and 
how the pathophysiology is affected. 
Summary and Recommendations 
1. There have been few published randomized trials of 
management of infertility in endometriosis. 
2. Before planning fertility management in endometriosis 
patients, women’s age, duration of infertility, other combined 
causes of infertility, ovarian reserve, severity of pain, and stage of 
endometriosis should be thoroughly evaluated. Sufficient information 
about the patient’s condition and management options should be 
provided. 
3. When laparoscopy is performed, the operator must ablate or 
excise the endometriotic lesion and restore normal pelvic anatomy as 
completely, and as safely, as possible. Surgery might improve fertility. 
However, repeated ovarian surgery should be avoided. If natural 
conception does not occur within 1 year after surgery, the clinician 
may consider ART. 
4. In infertile, younger, patients with stage I/II endometriosis, 
expectant management or COS with IUI after surgical management 
should be considered. But, if the patient is >35 years of age, COS with 
IUI or IVF may be the preferred option.
5. In infertile patients with stage III/IV endometriosis, surgical 
management can be recommended. However, ART can be an 
effective alternative for older women with advanced stage or recurrent 
endometriosis. 
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